Iparomlimab and tuvonralimab (QL1706) combined definitive chemoradiotherapy in patients with locally advanced esophageal squamous cell carcinoma (QL1706-IIT-02): a single arm, phase 2 trial
伊帕罗利单抗和图沃拉利单抗(QL1706)联合根治性放化疗治疗局部晚期食管鳞状细胞癌患者(QL1706-IIT-02):一项单臂 II 期试验
期刊:EClinicalMedicine
影响因子:10
doi:10.1016/j.eclinm.2026.103758
Zhang, Wencheng; Zhang, Tian; Chen, Xi; Li, Jiacheng; Gao, Linrui; Jiang, Shengpeng; Wang, Yufei; Zheng, Zhunhao; Dong, Jie; Li, Zewei; Zhao, Gang; Cao, Fuliang; Bai, Na; Wang, Ping; Yan, Cihui; Pang, Qingsong